Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Meals and Vitamin Safety Resilience Programme within the Sudan, Baseline Report, 2021 – Sudan
SUMMARY
The FAO's Food and Nutrition Security Resilience Program (FNS-REPRO) is a US $ 28 million four-year program...
Health Tracker Market Measurement, Share and Prime Distributors – Apple Fitbit Inc., Xiaomi Inc.,...
Request a sample of customization pricing and purchase options
New Jersey, United States, - The latest report, Fitness Trackers Market Size 2021, by manufacturer,...